These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
169 related items for PubMed ID: 15252275
1. Effects of dopamine D3 receptor antagonists on spontaneous and agonist-reduced motor activity in NMRI mice and Wistar rats: comparative study with nafadotride, U 99194A and SB 277011. Gyertyán I, Sághy K. Behav Pharmacol; 2004 Jul; 15(4):253-62. PubMed ID: 15252275 [Abstract] [Full Text] [Related]
2. Dopamine D3 receptor ligands show place conditioning effect but do not influence cocaine-induced place preference. Gyertyán I, Gál K. Neuroreport; 2003 Jan 20; 14(1):93-8. PubMed ID: 12544838 [Abstract] [Full Text] [Related]
3. A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194. Audinot V, Newman-Tancredi A, Gobert A, Rivet JM, Brocco M, Lejeune F, Gluck L, Desposte I, Bervoets K, Dekeyne A, Millan MJ. J Pharmacol Exp Ther; 1998 Oct 20; 287(1):187-97. PubMed ID: 9765337 [Abstract] [Full Text] [Related]
8. The role of D2 and D3 dopamine receptors in the mediation of emesis in Cryptotis parva (the least shrew). Darmani NA, Zhao W, Ahmad B. J Neural Transm (Vienna); 1999 Jan 01; 106(11-12):1045-61. PubMed ID: 10651102 [Abstract] [Full Text] [Related]
10. Discriminative stimulus properties of the dopamine D3 receptor agonists, PD128,907 and 7-OH-DPAT: a comparative characterization with novel ligands at D3 versus D2 receptors. Millan MJ, Girardon S, Monneyron S, Dekeyne A. Neuropharmacology; 2000 Feb 14; 39(4):586-98. PubMed ID: 10728880 [Abstract] [Full Text] [Related]
11. Antidepressant drugs attenuate 7-OH-DPAT-induced hypoactivity in rats. Rogóz Z, Dziedzicka-Wasylewska M. Pol J Pharmacol; 2000 Feb 14; 52(5):331-6. PubMed ID: 11334224 [Abstract] [Full Text] [Related]
12. Heterogeneity of behavioural profile between three new putative selective D3 dopamine receptor antagonists using an ethologically based approach. Clifford JJ, Waddington JL. Psychopharmacology (Berl); 1998 Apr 14; 136(3):284-90. PubMed ID: 9566814 [Abstract] [Full Text] [Related]
13. Locomotor hypoactivity and motor disturbances--behavioral effects induced by intracerebellar microinjections of dopaminergic DA-D2/D3 receptor agonists. Kolasiewicz W, Maj J. Pol J Pharmacol; 2001 Apr 14; 53(5):509-15. PubMed ID: 11990070 [Abstract] [Full Text] [Related]
19. Biphasic effects of D3-receptor agonists, 7-OH-DPAT and PD128907, on the D1-receptor agonist-induced hyperactivity in mice. Mori T, Murase K, Tanaka J, Ichimaru Y. Jpn J Pharmacol; 1997 Mar 14; 73(3):251-4. PubMed ID: 9127821 [Abstract] [Full Text] [Related]